News
2don MSN
A new study shows that while decentralized clinical trials (DCTs) are making research more accessible, they also bring ...
2d
News Medical on MSNInnovative immunotherapy trial opens for newly-diagnosed glioblastoma patientsA UCL-sponsored clinical trial for patients newly diagnosed with glioblastoma, an aggressive form of brain cancer, has opened ...
One of the most common misconceptions I hear is that trials are only for people who are seriously ill. In reality, healthy ...
Meeting Clinical Trial Demand. Goodman opened with some alarming statistics: there’s an expectation of a 49% rise in cancer incidence by 2050 and approximately 2000 new trials start each year in ...
Panelists highlight that patient advocacy is crucial in improving high-risk acute myeloid leukemia (AML) outcomes by ...
A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...
Discover why diverse patient voices, especially first-time participants, are key to improving clinical trials. Boost ...
There is an urgent need for more inclusive and community-focused cancer clinical trials, according to Kimberly (Cary) ...
5d
Clinical Trials Arena on MSNProtocol flexibility and navigating the US geopolitical landscape in oncology clinical trialsAt CTO East Coast, experts reflected on designing oncology clinical trials for success and how to account for a shifting ...
OSAKA, Japan, June 10, 2025 /PRNewswire/ -- Linical, a leader in clinical research services, is proud to celebrate its 20th anniversary — a milestone that reflects two decades of dedication ...
Some clinical trial sponsors are reluctant to provide financial support because of the current legal landscape. ... Passing this legislation will support patients and continued medical innovation.
The randomized SUMIT-BC trial is evaluating the efficacy and safety of samuraciclib in combination with fulvestrant vs. fulvestrant alone in patients with HR+, HER2- locally advanced or metastatic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results